HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $52,016 | -28.2% | 34,448 | +18.9% | 0.00% | -100.0% |
| Q4 2022 | $72,403 | -46.4% | 28,961 | -10.1% | 0.00% | 0.0% |
| Q3 2022 | $135,000 | +75.3% | 32,232 | +16.4% | 0.00% | 0.0% |
| Q2 2022 | $77,000 | -48.7% | 27,680 | +5.7% | 0.00% | 0.0% |
| Q1 2022 | $150,000 | -37.0% | 26,177 | +0.5% | 0.00% | -50.0% |
| Q4 2021 | $238,000 | -15.6% | 26,057 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $282,000 | -23.0% | 26,351 | +11.6% | 0.00% | -33.3% |
| Q2 2021 | $366,000 | -10.1% | 23,602 | -6.1% | 0.00% | -25.0% |
| Q1 2021 | $407,000 | -23.2% | 25,126 | +0.4% | 0.00% | -20.0% |
| Q4 2020 | $530,000 | +37.7% | 25,031 | -3.7% | 0.01% | +25.0% |
| Q3 2020 | $385,000 | +35.6% | 25,982 | +34.6% | 0.00% | 0.0% |
| Q2 2020 | $284,000 | +20.3% | 19,309 | -3.9% | 0.00% | 0.0% |
| Q1 2020 | $236,000 | – | 20,084 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |